RESUMO
In response to virus induction a culture of donor leukocytes alongside with interferon (IF-alpha) produced a factor of tumor necrosis (TNF). The kinetics of TNF and IF-alpha biosynthesis did not depend on the kind of IF used for priming, was rapid, with maximum production within 7-8 hours. Antibodies to IF-alpha and IF-alpha had no effect on TNF production, while antibody to TNF did not reduce IF-alpha yields. TNF in detectable titres was present in medical preparations of native IF-alpha but was absent in preparations of recombinant IF-alpha and IF-alpha as well as in an injection preparation of IF purified by chemical methods.
Assuntos
Contaminação de Medicamentos , Interferon-alfa/análise , Fator de Necrose Tumoral alfa/análise , Anticorpos/imunologia , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/metabolismo , Efeito Citopatogênico Viral/efeitos dos fármacos , Humanos , Indutores de Interferon/farmacologia , Interferon Tipo I/análise , Interferon-alfa/biossíntese , Interferon-alfa/imunologia , Leucócitos/efeitos dos fármacos , Leucócitos/metabolismo , Vírus da Doença de Newcastle , Proteínas Recombinantes , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/imunologia , Vírus da Estomatite Vesicular Indiana/efeitos dos fármacos , Vírus da Estomatite Vesicular Indiana/patogenicidadeRESUMO
A 65-year-old female patient has been orally taking corticosteroids (8 pills of prednisolone) for a severe form of bronchial asthma. In 1979 Kaposi's sarcoma was diagnosed for the first time; the diagnosis has been histologically confirmed. Several times the patient has been effectively treated with prospidin. The disease course got worse from 1984 on: the eruptions disseminated and the condition recurred every 2-3 months. This case is remarkable because Kaposi's sarcoma has developed in a patient treated with corticosteroids for asthma for a long time.
Assuntos
Prednisolona/efeitos adversos , Purinas , Sarcoma de Kaposi/induzido quimicamente , Neoplasias Cutâneas/induzido quimicamente , Idoso , Antineoplásicos/administração & dosagem , Asma/complicações , Asma/tratamento farmacológico , Aziridinas/administração & dosagem , Doença Crônica , Quimioterapia Combinada , Feminino , Humanos , Prednisolona/administração & dosagem , Prospídio/efeitos adversos , Sarcoma de Kaposi/tratamento farmacológico , Sarcoma de Kaposi/patologia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia , Fatores de TempoRESUMO
Analysis of 66 cases with neurodermatitis has made it possible to distinguish five conditions: atopic dermatitis, diffuse, disseminated, or local neurodermatitis, prurigo. Each of these nosologic entities in characterized by a specific course. The authors consider that the term 'atopic dermatitis' is inadequate and should be changed.